Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma-Reference-Cited by-同舟云学术

Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma

Published:2016-01 Issue:1 Volume:6 Page:e007709
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Molfino Nestor A,Kuna Piotr,Leff Jonathan A,Oh Chad K,Singh Dave,Chernow Marlene,Sutton Brian,Yarranton Geoffrey

Publisher

BMJ

Subject

General Medicine

Reference41 articles.

1. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program;Moore;Am J Respir Crit Care Med,2010

2. Asthma outcomes: healthcare utilization and costs;Akinbami;J Allergy Clin Immunol,2012

3. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics;Wenzel;Am J Respir Crit Care Med,1999

4. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8;Gibson;Chest,2001

5. Non-eosinophilic asthma: importance and possible mechanisms;Douwes;Thorax,2002

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GMCSF: More an Inflammatory Immune ‘Cytokine’ Than a Growth Factor;Indian Journal of Rheumatology;2024-06-23

2. Treatment with onion bulb extract both prevents and reverses allergic inflammation in a murine model of asthma;Pharmaceutical Biology;2024-04-08

3. Promising treatment biomarkers in asthma;Frontiers in Drug Safety and Regulation;2023-11-07

4. IL-5 and GM-CSF, but Not IL-3, Promote the Proliferative Properties of Inflammatory-like and Lung Resident-like Eosinophils in the Blood of Asthma Patients;Cells;2022-11-28

5. Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain;Pain;2022-11